Pages

Friday, November 26, 2010

India's first Stem Cell Therapy


Stem Cell Therapy is a new step towards treating the patients those who are suffering from critical diseases in India. India's first Stem Cell Conclave was held in Mumbai in a presence of renowned actress and former model Lisa Rey along with Chief Executive Officer of Cyro-Save Group,Dr. Mrinalini Chaturvedi of , Chief Executive Officer of Cyro-Save Group,Arnoud Van Tulder and Managing Director of StemOne Biologicals,Chaitanya Purandare. Stem Cell Conclave and Exhibition is one of its kind in India offers a comprehensive Knowledge to the common man on the Various benifits of stem cell therapy, its reach and utility.
According to Dr. Mrinalini Chaturvedi, Stem cell therapy is a kind of therapy in which a persons body stem cell is taken in a form of cord blood and bone marrow which is preserved in a stem cell bank and this stem cell will cure the patients those who are suffering from diseases like Leukemia,Diabities,Cancer etc. Stem Cell Therapy can cure more than 80 diseases and the Indian doctors and people has to know about this Therapy and promote awareness across India. Dr. Chaturvedi also mentioned about Lisa Rey as she was also suffering from a disease like multiple myeloma which is treated by stem cell therapy.

While speaking to the Media, Lisa Rey said,"I was suffering from the disease and which is cured by stem cell transplant and this is the reason I am associated with this Stem Cell Therapy. I am a cancer graduate and I know more about Stem Cell Therapy as it has cured my disease and I like to aware people in India for the Stem Cell Therapy."

On the Other hand,Dr. Mrinalini Chaturvedi said,"Stem cell regenaration is best for curing the disease and there is a needs to be an awareness in India about Stem Cell Therapy. Stem Cells are available in banks and the heart diseases,diabetes will cure by this Therapy. Stem cell therapy is also affordable for patients in India and there are the major hospitals in India were stem Cell therapy is already started."

No comments:

Post a Comment